Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
1998-1-30
pubmed:abstractText
Fresh operative cells from 27 renal cell carcinomas (RCC) were cultured in vitro for the determination of in vitro drug sensitivity. Two samples were not culturable. Incubation was carried out in triplicate in the presence and absence of various concentrations of chemotherapeutic agents. Sensitivity of the tumour cells to interferon-alpha (IFN-alpha), cisplatin (CDDP), mitomycin C (MMC), vinblastine (VBL), doxorubicin (DOX), etoposide (ETOP), bleomycin (BLM), vincristine (VCR) were tested by a colorimetric assay using MTT. A preexposure viability over 75% was essential for in vitro drug sensitivity assay (IVDSA). Sensitivity was determined by a more than 50 +/- 2 SD% reduction from the control absorbance. All eight drugs in their low concentrations exhibited cell proliferation inhibition in 0-12% of RCCs. On the other hand, IFN-alpha in its higher concentration (60 IU/ml) was effective in 88% of RCCs. After IFN, CDDP was found to be the second most effective drug in its higher concentration (36% efficacy). The results indicate that IFN appears to be the most effective in vitro agent in our 25 RCCs and the clinical trials either as a monotherapy or multiple combinations of various agents should include IFNs for the treatment of RCC.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
0301-1623
pubmed:author
pubmed:issnType
Print
pubmed:volume
29
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
421-6
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed-meshheading:9405998-Adult, pubmed-meshheading:9405998-Aged, pubmed-meshheading:9405998-Antineoplastic Agents, pubmed-meshheading:9405998-Bleomycin, pubmed-meshheading:9405998-Carcinoma, Renal Cell, pubmed-meshheading:9405998-Cell Division, pubmed-meshheading:9405998-Cell Survival, pubmed-meshheading:9405998-Cisplatin, pubmed-meshheading:9405998-Dose-Response Relationship, Drug, pubmed-meshheading:9405998-Doxorubicin, pubmed-meshheading:9405998-Drug Screening Assays, Antitumor, pubmed-meshheading:9405998-Etoposide, pubmed-meshheading:9405998-Female, pubmed-meshheading:9405998-Humans, pubmed-meshheading:9405998-Interferon-alpha, pubmed-meshheading:9405998-Kidney Neoplasms, pubmed-meshheading:9405998-Male, pubmed-meshheading:9405998-Middle Aged, pubmed-meshheading:9405998-Mitomycin, pubmed-meshheading:9405998-Recombinant Proteins, pubmed-meshheading:9405998-Tumor Cells, Cultured, pubmed-meshheading:9405998-Vinblastine, pubmed-meshheading:9405998-Vincristine
pubmed:year
1997
pubmed:articleTitle
Determination of in vitro drug sensitivity to a panel of cystostatic drugs and interferon alpha-2b in patients with renal cell carcinoma.
pubmed:affiliation
Department of Urology, Ankara University, Ibn-i Sina Hospital, Turkey.
pubmed:publicationType
Journal Article